Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies. Journal of Hepatology. 2025; 83(5):1128-1141.
A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines. European Journal of Human Genetics. 2025; 33(10):1252-1263.
Interleukin 8-CXCR2-mediated neutrophil extracellular trap formation in biliary atresia associated with neutrophil extracellular trap-induced stellate cell activation. Hepatology. 2025; 82(3):552-565.
Pediatric endoscopic ultrasound-guided liver biopsy: 3-year experience. Journal of Pediatric Gastroenterology and Nutrition. 2025; 80(5):920-925.
Magnetic resonance cholangiopancreatography for suspected cholangiopathy in children and young adults: a multi-reader agreement study. Pediatric Radiology. 2025; 55(3):479-487.
The relationship between serum bile acids and event-free survival following the use of maralixibat for progressive familial intrahepatic cholestasis: data from MARCH/MARCH-ON. Digestive and Liver Disease. 2025; 57:s67-s68.
Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease. Hepatology Communications. 2025; 9(1).
Prospective Multicenter Longitudinal Measurement of Liver Stiffness in School-Age Children With Cholestatic Liver Disease. Gastro Hep Advances. 2025; 4(10):100788.
DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers. 2024; 17(1).
Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts. Scientific Reports. 2024; 14(1):29307.
Association Between MR Elastography Liver Stiffness and Histologic Liver Fibrosis in Children and Young Adults With Autoimmune Liver Disease. American Journal of Roentgenology. 2024; 223(1):e2431108.
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Gastroenterology and Hepatology. 2024; 9(7):620-631.
Liver disease and transplantation in telomere biology disorders: An international multicenter cohort. Hepatology Communications. 2024; 8(7).
Su2029 INTERVENTIONAL RADIOLOGY VS. ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSIES IN PEDIATRIC MASLD. Gastroenterology. 2024; 166(5):s-898.
Red cell abnormalities characterized by ektacytometry in children with cholestasis. Pediatric Research. 2024; 95(4):1035-1040.
Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitis. Journal of Hepatology. 2024; 80(1):e26-e28.
Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases. Hepatology Communications. 2024; 8(1).
Case Report: Childhood Erythrocytosis due to Hypermanganesemia Caused by Homozygous SLC30A10 Mutation. Frontiers in Hematology. 2024; 3.
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease. Hepatology Communications. 2023; 7(11).
Customized Postoperative Therapy Improves Bile Drainage in Biliary Atresia: A Single Center Preliminary Report. Journal of Pediatric Surgery. 2023; 58(8):1483-1488.
Recent Increase in Incidence of Severe Acute Hepatitis of Unknown Etiology in Children is Associated with Infection with Adenovirus and Other Nonhepatotropic Viruses. Journal of Pediatrics. 2023; 259:113439.
Presence of Alpha 1 Antitrypsin Risk Variants is Not Associated With Histologic Severity of Pediatric NAFLD. Journal of Pediatric Gastroenterology and Nutrition. 2023; 77(2):166-170.
Corrected T1 Mapping in Children and Young Adults With Autoimmune Liver Disease: Correlation With Histology. American Journal of Roentgenology. 2023; 220(6):901-902.
Longitudinal changes in quantitative magnetic resonance imaging metrics in children and young adults with autoimmune liver disease. Abdominal Radiology. 2023; 48(6):1933-1944.
Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children. Hepatology Communications. 2023; 7(6).
FRI-350 Genetic predisposition for liver inflammation and response to anti-cholestatic therapy in experimental sclerosing cholangitis. Journal of Hepatology. 2023; 78:s417-s418.
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology. 2023; 77(2):530-545.
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis. Science Translational Medicine. 2022; 14(675):eabi4354.
Children undergoing early liver re-transplantation for primary non-function have improved survival. Pediatric Transplantation. 2022; 26(7):e14347.
Differential recruitment of monocyte-derived macrophages in control and stellate cell-depleted mice during recurrent carbon tetrachloride-induced acute liver injury. Journal of Cellular Physiology. 2022; 237(11):4215-4225.
Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia. Hepatology. 2022; 76(3):712-726.
Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study. Hepatology Communications. 2022; 6(9):2379-2390.
Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome. Hepatology Communications. 2022; 6(8):1922-1933.
Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease. American Journal of Roentgenology. 2022; 219(1):142-150.
Pediatric Living Donor Liver Transplantation Outcomes-Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks? Liver Transplantation. 2022; 28(6):928-930.
Total pancreatectomy with islet autotransplantation in a child with pancreatic kaposiform hemangioendothelioma. Journal of Pediatric Surgery Case Reports. 2022; 81:102266.
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency. JHEP Reports. 2022; 4(4):100446.
Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent-perceived general health. Liver International. 2022; 42(2):394-401.
Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease. Abdominal Radiology. 2022; 47(2):672-683.
Clinically available testing options resulting in diagnosis in post-exome clinic at one medical center. Frontiers in Genetics. 2022; 13:887698.